Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06444763
PHASE3

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Sponsor: RDC Clinical Pty Ltd

View on ClinicalTrials.gov

Summary

This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on chronic inflammation, mobility and muscle and joint pain in an otherwise healthy population of adults over 45 years old over 10 weeks with 8 weeks supplementation. This is PART B of the study.

Official title: Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled Study

Key Details

Gender

All

Age Range

45 Years - Any

Study Type

INTERVENTIONAL

Enrollment

97

Start Date

2025-02-27

Completion Date

2026-02-16

Last Updated

2026-11-13

Healthy Volunteers

Yes

Interventions

DRUG

Maolactin

Once daily dose of 2 capsules containing a total of 500mg/day Maolactin

DRUG

Maltodextrin

Once daily dose of 2 capsules of Maltodextrin containing a total of 0mg/day Maolactin

Locations (1)

RDC Clinical Pty Ltd

Brisbane, Queensland, Australia